Identifying risk factors for complications after liver transplantation
Verification of Prognostic Risk Factors of Thrombohemorrhagic Complications in Early Follow-up Period in Recipients After Living Related Liver Transplantation
Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov · NCT06169592
This study is trying to find out what factors can lead to bleeding and clotting problems after liver transplant surgery in patients with severe liver disease to help improve their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov (other) |
| Locations | 1 site (Tashkent) |
| Trial ID | NCT06169592 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance outcomes for patients undergoing related liver transplantation by identifying predictors of thrombohemorrhagic complications. It focuses on patients with end-stage liver cirrhosis and seeks to optimize a comprehensive prevention program for these complications. The study will involve monitoring and analyzing various risk factors that may influence the hemostatic system post-transplantation. By understanding these factors, the study hopes to improve patient care and outcomes following liver transplantation.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 70 with end-stage liver cirrhosis who can provide informed consent.
Not a fit: Patients who are pregnant, have hematological diseases affecting hemostasis, or severe concomitant disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and reduced complications for patients undergoing liver transplantation.
How similar studies have performed: While this approach is focused on a specific aspect of liver transplantation, similar studies have shown promise in identifying risk factors for complications in transplant patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age over 18 years and up to 70 years; * Signed informed consent for inclusion to the study; * End stage liver cirrhosis. Exclusion Criteria: * Pregnancy; * Extrahepatic factors influencing systemic hemostasis; * Concomitant hematological diseases affecting the hemostatic system; * Severe concomitant disorders.
Where this trial is running
Tashkent
- Republican specialized scientific and practical medical center of surgery named after academician V.Vakhidov — Tashkent, Uzbekistan (RECRUITING)
Study contacts
- Study coordinator: Azam Babadjanov, Professor
- Email: azambabadjanov@gmail.com
- Phone: +998901751703
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Liver Cirrhosis, Liver Transplant, Complications